These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31636239)

  • 21. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
    Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Inhibitory Effects of Low-Dose Ionizing Radiation in IgE-Mediated Allergic Responses.
    Joo HM; Kang SJ; Nam SY; Yang KH; Kim CS; Lee IK; Kim JY
    PLoS One; 2015; 10(8):e0136394. PubMed ID: 26317642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.
    Kraft S; Fleming T; Billingsley JM; Lin SY; Jouvin MH; Storz P; Kinet JP
    J Exp Med; 2005 Feb; 201(3):385-96. PubMed ID: 15684326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rat monoclonal anti-murine IgE antibody removes IgE molecules already bound to mast cells or basophilic leukemia cells, resulting in the inhibition of systemic anaphylaxis and passive cutaneous anaphylaxis.
    Miyajima H; Watanabe N; Ovary Z; Okumura K; Hirano T
    Int Arch Allergy Immunol; 2002 May; 128(1):24-32. PubMed ID: 12037398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species Specificity on Interaction between IgE and FcεRI.
    Li X; Wang N; Zhao Y; Zhang Y; Liu Z
    Curr Pharm Biotechnol; 2019; 20(9):690-695. PubMed ID: 31258078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo.
    Hunt J; Bracher MG; Shi J; Fleury S; Dombrowicz D; Gould HJ; Sutton BJ; Beavil AJ
    J Biol Chem; 2008 Oct; 283(44):29882-7. PubMed ID: 18703499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI.
    Sabban S; Ye H; Helm B
    J Vis Exp; 2014 Nov; (93):e52222. PubMed ID: 25406512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
    Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
    J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenine suppresses IgE-mediated mast cell activation.
    Silwal P; Shin K; Choi S; Kang SW; Park JB; Lee HJ; Koo SJ; Chung KH; Namgung U; Lim K; Heo JY; Park JI; Park SK
    Mol Immunol; 2015 Jun; 65(2):242-9. PubMed ID: 25700347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
    Laffer S; Hogbom E; Roux KH; Sperr WR; Valent P; Bankl HC; Vangelista L; Kricek F; Kraft D; Grönlund H; Valenta R
    J Allergy Clin Immunol; 2001 Sep; 108(3):409-16. PubMed ID: 11544461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the FcepsilonRI beta-chain in allergic diseases.
    Kraft S; Rana S; Jouvin MH; Kinet JP
    Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond.
    Dema B; Suzuki R; Rivera J
    Int Arch Allergy Immunol; 2014; 164(4):271-9. PubMed ID: 25227903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgE in the pathophysiology and therapy of food allergy.
    Michelet M; Balbino B; Guilleminault L; Reber LL
    Eur J Immunol; 2021 Mar; 51(3):531-543. PubMed ID: 33527384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
    Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel eremophilane lactone inhibits FcεRI-dependent release of pro-inflammatory mediators: structure-dependent bioactivity.
    Qian F; Guo G; Li Y; Kulka M
    Inflamm Res; 2016 Apr; 65(4):303-11. PubMed ID: 26791350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
    Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.